Updating results

113 results

Sort: Relevance | Date

Rapid tests for Group A Streptococcal infections in people with a sore throat: diagnostics consultation

We are listening to your views on this diagnostics guidance. Comments close 07 August 2019.

Diagnostics guidance In consultation

Lower urinary tract symptoms in men: assessment and management: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 07 August 2019.

Clinical guideline In consultation

Reducing sexually transmitted infections: draft scope consultation

We are listening to your views on this NICE guideline. Comments close 18 September 2019.

NICE guideline In consultation

Balloon dilation for eustachian tube dysfunction: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 September 2019.

Interventional procedures guidance In consultation

Balloon cryoablation for Barrett's oesophagus: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 September 2019.

Interventional procedures guidance In consultation

Balloon cryoablation for squamous dysplasia of the oesophagus: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 September 2019.

Interventional procedures guidance In consultation

Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal: draft scope consultation

We are listening to your views on this NICE guideline. Comments close 26 September 2019.

NICE guideline In consultation

Fetal alcohol spectrum disorder: topic engagement

We are listening to your views on this quality standard. Comments close 08 October 2019.

Quality standard In consultation

Cerebral palsy in adults: quality standard consultation

We are listening to your views on this quality standard. Comments close 30 September 2019.

Quality standard In consultation

Healthcare-associated infections: prevention and control: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 20 September 2019.

Public health guideline In consultation

Neonatal parenteral nutrition: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 18 October 2019.

NICE guideline In consultation

Faltering growth: topic engagement

We are listening to your views on this quality standard. Comments close 02 October 2019.

Quality standard In consultation

Community pharmacies: promoting health and wellbeing: topic engagement

We are listening to your views on this quality standard. Comments close 02 October 2019.

Quality standard In consultation

Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management: call for evidence

We are listening to your views on this NICE guideline. Comments close 16 October 2019.

NICE guideline In consultation

Fever in under 5s: assessment and initial management: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 19 September 2019.

NICE guideline In consultation

Intrapartum care: women with existing medical conditions or obstetric complications and their babies: quality standard consultation

We are listening to your views on this quality standard. Comments close 23 September 2019.

Quality standard In consultation

Brentuximab vedotin for untreated CD30-positive peripheral T-cell lymphoma ID1586

Proposed [GID-TA10514] Expected publication date: TBC

Technology appraisal guidance Proposed

Prevention and non-surgical treatment of pelvic floor failure/incompetence/prolapse

Proposed [GID-QS10129] Expected publication date: TBC

Quality standard Proposed

Rivaroxaban for treating chronic heart failure [ID1462]

Proposed [GID-TA10393] Expected publication date: TBC

Technology appraisal guidance Proposed

Pernicious Anaemia

Proposed [GID-QS10130] Expected publication date: TBC

Quality standard Proposed

Abicipar pegol for treating wet age-related macular degeneration ID1533

Proposed [GID-TA10511] Expected publication date: TBC

Technology appraisal guidance Proposed

Luspatercept for treating anaemia caused by myelodysplastic syndromes [ID1550]

Proposed [GID-TA10508] Expected publication date: TBC

Technology appraisal guidance Proposed

Angiotensin II for treating vasopressor-resistant hypotension caused by distributive shock ID1588

Proposed [GID-TA10507] Expected publication date: TBC

Technology appraisal guidance Proposed

Luspatercept for treating beta-thalassaemia ID1554

Proposed [GID-TA10506] Expected publication date: TBC

Technology appraisal guidance Proposed

Voxelotor for treating sickle cell disease [ID1403]

Proposed [GID-TA10505] Expected publication date: TBC

Technology appraisal guidance Proposed

Midostaurin for treating advanced systemic mastocytosis ID1573

Proposed [GID-TA10503] Expected publication date: TBC

Technology appraisal guidance Proposed

Nivolumab with ipilimumab for untreated recurrent or metastatic squamous cell cancer of the head and neck cancer ID1429

Proposed [GID-TA10512] Expected publication date: TBC

Technology appraisal guidance Proposed

Dulaglutide for treating type 2 diabetes [ID1451]

Proposed [GID-TA10439] Expected publication date: TBC

Technology appraisal guidance Proposed

Semaglutide for treating type 2 diabetes (ID1450)

Proposed [GID-TA10438] Expected publication date: TBC

Technology appraisal guidance Proposed

Mexiletine for treating myotonia in adults with non-dystrophic myotonic disorders ID1488

Proposed [GID-TA10432] Expected publication date: TBC

Technology appraisal guidance Proposed

Netarsudil for treating open angle glaucoma or ocular hypertension [ID1078]

Proposed [GID-TA10431] Expected publication date: TBC

Technology appraisal guidance Proposed

Solriamfetol for treating excessive sleepiness caused by narcolepsy or obstructive sleep apnoea [ID1499]

Proposed [GID-TA10430] Expected publication date: TBC

Technology appraisal guidance Proposed

Depression in adults (update)

Proposed [GID-QS10057] Expected publication date: TBC

Quality standard Proposed

Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source (ID1417)

Proposed [GID-TA10426] Expected publication date: TBC

Technology appraisal guidance Proposed

Dupilumab for treating chronic rhinosinusitis with nasal polyps ID1179

Proposed [GID-TA10450] Expected publication date: TBC

Technology appraisal guidance Proposed

Galcanezumab for preventing cluster headache [ID1212]

Proposed [GID-TA10425] Expected publication date: TBC

Technology appraisal guidance Proposed

Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

Proposed [GID-HST10019] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Pegvaliase for treating phenylketonuria [ID1110]

Proposed [GID-TA10345] Expected publication date: TBC

Technology appraisal guidance Proposed

Adrenal dysfunction

Proposed [GID-QS10038] Expected publication date: TBC

Quality standard Proposed

Acne

Proposed [GID-QS10036] Expected publication date: TBC

Quality standard Proposed

Abdominal aortic aneurysm

Proposed [GID-QS10035] Expected publication date: TBC

Quality standard Proposed

Intravenous zanamivir for treating influenza in hospital [ID1196]

Proposed [GID-TA10298] Expected publication date: TBC

Technology appraisal guidance Proposed

Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing elective surgery [ID1149]

Proposed [GID-TA10297] Expected publication date: TBC

Technology appraisal guidance Proposed

Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]

Proposed [GID-TA10336] Expected publication date: TBC

Technology appraisal guidance Proposed

STG320 for treating persistent allergic rhinitis caused by house dust mites (ID1278)

Proposed [GID-TA10279] Expected publication date: TBC

Technology appraisal guidance Proposed

Mepolizumab for treating chronic obstructive pulmonary disease (ID1237)

Proposed [GID-TA10239] Expected publication date: TBC

Technology appraisal guidance Proposed

Avacopan for treating anti-neutrophil cytoplasmic antibody-associated vasculitis ID1178

Proposed [GID-TA10199] Expected publication date: TBC

Technology appraisal guidance Proposed

Dexamethasone intracanalicular insert for treating inflammation and pain after cataract surgery ID1154

Proposed [GID-TA10198] Expected publication date: TBC

Technology appraisal guidance Proposed

Tocilizumab for treating systemic sclerosis (ID1396)

Proposed [GID-TA10346] Expected publication date: TBC

Technology appraisal guidance Proposed

Infant, children and young people's experience of health care

Proposed [GID-QS10102] Expected publication date: TBC

Quality standard Proposed